Is The Society For The Advancement Of Blood Management Legit?

The Society For The Advancement Of Blood Management demonstrates a generally stable financial position, with recent revenues of $686,348 in 2023 slightly exceeding expenses of $660,548, leading to a modest surplus. While assets have fluctuated over the years, from a high of $865,961 in 2015 to $412,577 in 2023, the organization maintains a positive asset-to-liability ratio, indicating solvency. The consistent reporting of 0% officer compensation across all available filings suggests a commitment to minimizing administrative overhead related to executive pay, which is a positive indicator for spending efficiency. The organization's financial health appears sound, with revenues generally covering expenses, though there have been periods of deficit spending, such as in 2022 where expenses ($592,880) exceeded revenue ($477,956). The lack of detailed functional expense breakdowns (program, administrative, fundraising) in the provided data makes a precise assessment of spending efficiency challenging. However, the absence of reported officer compensation is a strong point for transparency and efficient use of funds. Overall, the Society For The Advancement Of Blood Management appears to be a financially responsible organization, consistently filing its IRS 990s and demonstrating a commitment to its mission without incurring executive compensation costs. Further detailed expense breakdowns would enhance the transparency report, but the available data suggests prudent financial management.